Gadolinium MRI Lawsuits

Other Pharmaceutical Lawsuits Eligible for Lawsuit Loans

Nephrogenic Systemic Fibrosis | Nephrogenic Fibrosing Dermopathy

Nephrogenic Systemic Fibrosis (NSF), formerly known as Nephrogenic Fibrosing Dermopathy (NFD), (dermopathy means disorder of skin) is a condition that, to date, has occurred only in people with severe kidney disease who have undergone one or more MRI's.

NSF is a bizarre systemic disorder with its most prominent and visible effects in the skin. As hundreds of additional emerging cases are studied, it is becoming clear that kidney disease seems to be a prerequisite for developing NSF because all currently known cases of NSF involve patients suffering from severe kidney dysfunction. Nephrogenic means starting with the kidney, so NSF (as opposed to NFD) is accepted as the terminology most accurately reflecting the disease.

What Is Gadolinium?

Gadolinium is a soft, malleable, silvery white rare earth metal that is never found in nature as the free element, but is contained in many rare minerals such as monazite and bastnäsite. It's symbol on the periodic chart of elements is Gd.

What Is Gadolinium MRI Contrast Agent?

Gadolinium is an element that is used in contrast dyes for magnetic resonance imaging (MRI) and magnetic resonance angiography (MRA). It helps doctors to better distinguish between blood vessels and nearby tissue.

The first toxic side effects of Gadolinium were discovered in 1997. Since that time, more than 1,000 cases have been diagnosed worldwide.

On May 23, 2007 the FDA issued a public health advisory and cited recent findings that clearly indicated Gadolinium-based MRI contrasting agents significantly increased the risk of developing Nephrogenic Systemic Fibrosis (NSF) or Nephrogenic Fibrosing Dermopathy (NFD).

There are five different Gadolinium MRI contrasting agents approved for use in the United States. They are Omniscan® (Gadodiamide) manufactured by GE Healthcare, OptiMARK® (Gadoversetamide) manufactured by Mallinckrodt and Tyco Healthcare, Magnevist® (Gadopentetate Dimeglumine) made by Bayer HealthCare, Berlex and Schering AG; ProHance® (Gadoteridol) and MultiHance® (Gadobenate Dimeglumine) both made by Bracco Diagnostics.

Nephrogenic Systemic Fibrosis Symptoms

People with NSF develop fibrosis of the skin and this may spread to the connective tissues and other organs of body. Some of the most common side effects include:

• Woody skin with texture of an orange peel
• Swelling and tightening of the skin
• Muscle weakness
• Difficulty flexing and extending the joints
• Loss of mobility
• Locking joints
• Pain in the hip or rib areas
• Eye discoloration (yellow spots on the eyes)
• Fibrosis of the skin and internal organs, skin thickening and waxing
• Red or dark skin patches and skin rashes
• Blister-like lesions
• Burning and itching skin

Nephrogenic Systemic Fibrosis

Recently, a number of Gadolinium lawsuits have been launched in response to the US Food and Drug Administration (FDA) announcement that Gadolinium-containing MRI contrast agents have been identified ad the cause of Nephrogenic Systemic Fibrosis or Nephrogenic Fibrosing Dermopathy in patients with kidney disease.

Nephrogenic Systemic Fibrosis and Nephrogenic Fibrosing Dermopathy is a relatively new medical syndrome and as more cases are discovered, researchers are beginning to understand more about it and are slowly getting a clearer medical picture of the disease.

What is known is that NSF is a progressive, currently incurable and irreversible disorder which causes the development of excessive scar tissue and thick, tight, hardened areas of skin which often cover the joints, resulting in severe limitations on movement. It frequently renders the victim unable to walk or fully move the joints of their arms, hands, legs and/or feet and many become dependent on a wheelchair within weeks of the onset.

There is currently no known cure or effective treatment for Nephrogenic Systemic Fibrosis or Nephrogenic Fibrosing Dermopathy and the disease can be excruciatingly painful, debilitating and has, in a number of cases so far, lead to death.

Lawsuit Funding: Make Your Life Easier With a Lawsuit Loan

Getting a lawsuit pre future settlement funding is simple and easy as long as you have a diagnosed case of NSF. Lawsuit funding is fast, free and easy to apply for and with no credit checks, no income or employment requirements, no monthly payments and no up-front or out-of-pocket costs, settlement loans are 100% RISK-FREE for plaintiffs and you only repay the advance if you win your case. If you lose your case or your case doesn't settle, YOU OWE US NOTHING! And with the growing number of Gadolinium cases, litigation financing is an excellent way for attorneys and law firms to to build or expand their practice.

A GADOLINIUM LAWSUIT CASH ADVANCE COULD PUT CASH IN YOUR HANDS IN AS LITTLE AS 48-72 HOURS!
No monthly payments No employment requirements Bad credit is no problem No credit is no problem No up-front fees or costs No out-of-pocket expenses	No interference with case management No payment until your case settles No payment if your case doesn't settle Approval process is FAST & EASY GUARANTEED LOW RATES! Prompt, professional & VERY DISCREET

THERE'S ZERO RISK ... SO WHY WAIT?

Does your Gadolinium MRI case qualify for lawsuit financing?
Find out now by calling us at 1-877-932-2628 or simply complete the info below.

Serving these cities & states: Alabama, Alaska, Arizona, Arkansas, California, Connecticut, Delaware, District of Columbia, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, Washington DC, West Virginia, Wisconsin and Wyoming. AL, AK, AZ, AR, CA, CT, DC, DE, FL, GA, HI, ID, IL, IN, IA, KY, LA, ME, MD, MA, MI, MN, MS, MO, MT, ND, NE, NV, NH, NJ, NM, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, VA, WA, WV & WY.